Article
Vaccine and oncogenic strains of gallid herpesvirus 2 contain specific subtype variations in the 5' region of the latency-associated transcript that evolve in vitro and in vivo.
Archives of virology - 1 Jan 2015
Labaille Jennifer, Lion Adrien, Boissel Elodie, Trapp Sascha, Nair Venugopal, Rasschaert Denis, Dambrine Ginette
Abstract excerpt
Gallid herpesvirus 2 (GaHV-2) is the alphaherpesvirus responsible for Marek's disease (MD), a T-cell lymphoma of chickens. The virulence of the GaHV-2 field strain is steadily increasing, but MD is still controlled by the CVI988/Rispens vaccine. We tried to determine distinguishing traits of the CVI988/Rispens vaccine by focusing on the 5' end region of the latency-associated transcript (5'LAT). It includes a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
